Lipocine (LPCN) Announces FDA Approval of Antares’ TLANDO
Summary: Lipocine Inc. , a clinical-stage biopharmaceutical company focused on developing innovative products for neuroendocrine and metabolic disorders, announced today that Antares…
Summary: Lipocine Inc. , a clinical-stage biopharmaceutical company focused on developing innovative products for neuroendocrine and metabolic disorders, announced today that Antares…
Summary : Halozyme Therapeutics has announced a formal agreement to acquire all of Antares Pharma’s outstanding shares in a deal worth about…